FDA Approvals

The US Food and Drug Administration (FDA) has granted orphan drug designation to Shire’s investigational mucosal addressin cell adhesion molecule-1...

Eli Lilly and Company announced that the U.S. FDA has approved Taltz® (ixekizumab) injection 80 mg/mL for the treatment of...

Capricor Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to...

Merck , known as MSD outside the United States and Canada announced that the U.S. FDA has approved ISENTRESS® (raltegravir),...

AstraZeneca announced that the US FDA has approved a new indication for Faslodex (fulvestrant), expanding the indication to include use...

Eagle Pharmaceuticals, Inc. announced that the United States Food and Drug Administration (“FDA”) has granted tentative approval for the Company’s...